Catalyst

Slingshot members are tracking this event:

Theravance Biopharma (TBPH) announces new developmental partnership with Celgene (CELG) for TD-6450, its multivalent NS5A inhibitor

Source Link:
http://seekingalpha.com/article/3612436-theravance-biopharmas-cryptic-new-partnership-celgene

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TBPH Community voting in process
CELG Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details The author of the article is long on TBPH
http://seekingalpha....
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Oct 28, 2015
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Phase 2a, Phase 2 Clinical Trial, Td-6450, Hepatitis C, Partnership
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.